Should combined brachytherapy/EBRT/ADT be the standard of care for men with high-risk prostate cancer?
Given the excellent results from the ASCENDE-RT trial, should we be combining EBRT and brachytherapy? What criteria do you use to determine when to use this approach?
Answer from: Radiation Oncologist at Academic Institution
The results of the ASCENDE-RT trial are obviously very encouraging and corroborate findings from single institution studies that combined brachytherapy and external beam radiotherapy in conjunction with hormonal therapy is associated with superior outcomes compared to dose escalated external beam ra...
Comments
Radiation Oncologist at CoxHealth Radiation Oncology Thank you for your thorough response, @Michae...
Answer from: Radiation Oncologist at Community Practice
I completely concur with @Michael J. Zelefsky's statements. The robust improvement in biochemical control with a relatively short median follow-up portends long-term improvents in clinical outcomes for these patients. As is stated in the question, it is important to keep in mind that this study did ...
Comments
Radiation Oncologist at CoxHealth Radiation Oncology I am not sure if it is kosher, scientifically or o...
Radiation Oncologist at Cancer Care Centers of Brevard I think the crux of the argument is that either te...
Radiation Oncologist at CoxHealth Radiation Oncology Thanks for your comment.
If there are limitations...
Thank you for your thorough response, @Michae...